Children with high BMIs should not use obesity medications like WeGovy, US doctors warn

• A task force of more than a dozen doctors warned against prescribing children weight-loss drugs like Ozempic.
• In 2023, the American Academy of Pediatrics suggested drug treatments for children with obesity in addition to lifestyle interventions.
• Health professionals continue to debate the safety and effectiveness of these drugs for adolescents.

With weight-loss drugs like WeGovy and Ozempic dominating many of today's consumer healthcare conversations, there's a mounting concern for a particularly vulnerable group: children.